Nav: Home

Rapamycin retards epigenetic ageing of keratinocytes

June 05, 2019

Cessation, or even retardation of the ageing process is an appealing notion that has captured the imagination of humans for millennia. Even if it were possible to rejuvenate our bodies or retard the ageing process, how do we measure this?

Age, as we know it, is clearly an inappropriate measurement because it is based purely on the passing of time, irrespective of biological changes in our body. A promising solution to this challenge is now in sight. In 2013, Steve Horvath (UCLA) described the remarkable mathematical precision by which chemical modifications on DNA called methylation, changes with age. With these methylation profiles, he derived a highly accurate age-predicting algorithm, which is essentially a time-independent yard-stick to measure age based on biology.

Teaming up with Ken Raj of Public Health England (UK) in 2018, Horvath generated an improved algorithm called the Skin and blood clock that is applicable to cultured cells as well as those in the body. By using this epigenetic clock, Raj and Horvath now demonstrate that Rapamycin's retardation of ageing, which has been documented in numerous animal species, also extends to human cells.

While admittedly this is on human cells rather than the body, this finding is nevertheless consistent with the independent observation that a variant of the MLST8 gene, which encodes part of the target of Rapamycin, is linked with increased rate of epigenetic ageing in humans. The harmonious convergence between observations from the bench using cultured cells and genome-wide association studies with human tissues, highlight the fidelity of this system, which has been derived and validated in humans, to test the effects of compounds on human ageing. Equally significant is the fact that Rapamycin has been well-documented to prevent arrested cells from becoming senescent - a process known as gero-conversion, which Raj and Horvath have previously demonstrated to be distinct from epigenetic ageing.

The Raj research team concluded, " that the life-extending property of rapamycin may be a resultant of its multiple actions which include, but not necessarily limited to suppression of cellular senescence and epigenetic aging, with the possibility of augmentation of cellular proliferative potential."

Hence it would appear that Rapamycin possesses the remarkable ability to inhibit not one, but two-independent pathways of ageing. While a two-for-one offer is common in retail, it is exceptionally rare in biology. Just as in retail, offers can come with a catch, and here it is important to note that this effect of rapamycin has yet to be widely tested on other cells types. This caveat notwithstanding, this exciting finding and the available tools and methods described by Raj and Horvath will no doubt encourage the search for even better compounds that may help in promoting healthy human ageing.
-end-
Full text - https://www.aging-us.com/article/101976/text

Keywords - Epigenetic ageing, Rapamycin

Correspondence to - Ken Raj Ken.raj@phe.gov.uk

About Aging

Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research as well as topics beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, cancer, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR among others), and approaches to modulating these signaling pathways.

Aging is published by Impact Journals.

To learn more about Aging, please visit http://www.Impactjournals.com

Impact Journals LLC

Related Rapamycin Articles:

The CNIO discovers that rapamycin has harmful effects when telomeres are short
The CNIO shows that an anti-aging strategy that extends life in normal mice, the treatment with rapamycin, is harmful when mice have short telomeres.
Rapamycin may slow skin aging, Drexel study reports
The search for youthfulness typically turns to lotions, supplements, serums and diets, but there may soon be a new option joining the fray.
Study: Rapamycin prevents age-related brain vascular deterioration
A newly released study found that rats of advanced age, treated with the drug rapamycin, maintained superior blood flow to the brain compared to younger, untreated rats.
Rapamycin for longevity -- Opinion article
The scientist discusses several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today.
Fruit flies live longer with combination drug treatment
A triple drug combination has been used to extend the lifespan of fruit flies by 48% in a new study led by UCL and the Max Planck Institute for Biology of Ageing, and published in Proceedings of the National Academy of Sciences (PNAS),
Rapamycin retards epigenetic ageing of keratinocytes
Age, as we know it, is clearly an inappropriate measurement because it is based purely on the passing of time, irrespective of biological changes in our body.
Reprogramming the wonder drug rapamycin allows creation of new small-molecule drugs
In the new study, the authors aimed to reprogram rapamycin by keeping the parts of rapamycin and tacrolimus that bind FKBP12 and changing the remaining half of the molecule in order to target completely new disease-associated proteins beyond mTOR and calcineurin.
Study: Ketogenic diet appears to prevent cognitive decline in mice
The Ketogenic Diet, simple caloric restriction, or the pharmaceutical rapamycin appear to improve neurovascular function and prevent cognitive decline in animal models.
Discovery of a cancer promoter offers pathway to overcome drug resistance
Geneticists at St. Jude Children's Research Hospital have discovered a previously unknown cell growth mechanism that makes a wide range of cancers resistant to rapamycin and related drugs.
Is topical rapamycin effective, safe to treat facial lesions?
Facial angiofibromas are disfiguring growths and these lesions occur in most people with tuberous sclerosis complex, a genetic disorder where growths can appear throughout the body. Current treatments for these facial growths include laser surgery, cryotherapy, dermabrasion and other similar procedures that can be painful and cause scarring but can't prevent recurrence of the lesions.The results of a clinical trial of 179 patients showed improvement in the appearance of these lesions with the use of topical rapamycin.
More Rapamycin News and Rapamycin Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Space
One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at Radiolab.org/donate.